FDA Peptide Update: Category 2 Removals Explained FDA Moves to Reevaluate Several Peptides American Med Spa Association The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica